A nurse is caring for a client who has borderline personality disorder (BPD). What should the nurse monitor in the client’s Medication Administration Record?

Initiating one-to-one nursing observation is the most crucial and immediate action the nurse should take in this scenario. Here's a detailed explanation:

Prioritizes Safety: The client has a recent history of a suicide attempt, indicating a high risk for self-harm. One-to-one observation ensures continuous monitoring, enabling prompt intervention if the client engages in any self-injurious behaviors or attempts. It prioritizes the client's safety and prevents further harm.

Addresses Acute Risk: The client's mental health conditions, including depression, substance abuse, and anorexia nervosa, create a complex and acute risk profile. One-to-one observation allows for close assessment of the client's mental state, behaviors, and potential triggers, enabling early identification of any escalating risk and timely implementation of appropriate interventions.

Provides Support and Stabilization: The presence of a dedicated nurse provides emotional support, reassurance, and a sense of security for the client during this vulnerable period. It can help reduce anxiety and distress, promote engagement in treatment, and facilitate stabilization.

Gathers Essential Information: While observing the client, the nurse can gather valuable information about their behavior patterns, coping mechanisms, communication style, and potential triggers. This information is essential for developing a comprehensive and individualized treatment plan.

Facilitates Trust and Rapport: One-to-one observation provides an opportunity for the nurse to establish a therapeutic relationship with the client, build trust, and promote open communication. This foundation is crucial for effective assessment, intervention, and ongoing care

Choice C rationale:

Sodium level is a critical electrolyte that plays a vital role in maintaining fluid balance, nerve and muscle function, and blood pressure. Naltrexone, one of the medications the patient is taking, has the potential to cause hyponatremia (low sodium levels) as a side effect. Hyponatremia can manifest with various symptoms, including headache, nausea, vomiting, confusion, seizures, and even coma in severe cases. Prompt recognition and management of hyponatremia are crucial to prevent serious complications.

Rationale for Immediate

Potential for Hyponatremia: Naltrexone, an opioid antagonist, can interfere with the body's ability to regulate sodium levels, leading to hyponatremia.

Serious Consequences of Hyponatremia: Low sodium levels can disrupt vital bodily functions, potentially causing neurological symptoms, seizures, and even coma.

Need for Prompt Intervention: Early detection and correction of hyponatremia are essential to prevent adverse outcomes.

Monitoring and Management: The nurse should assess the patient's sodium level, monitor for signs and symptoms of hyponatremia, and initiate appropriate interventions as needed, such as fluid restriction or electrolyte replacement.

Choice D rationale:

Hepatitis Viral Study (HAA) results are essential for determining the patient's hepatitis A status. Hepatitis A is a highly contagious liver infection that can cause significant illness. Fluoxetine, the other medication the patient is taking, can potentially cause liver damage in rare cases. Therefore, it's crucial to ensure that the patient does not have hepatitis A before initiating or continuing Fluoxetine therapy.

Rationale for Immediate

Potential Liver Injury: Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), has a rare but potential risk of hepatotoxicity (liver damage).

Hepatitis A Risk: Hepatitis A infection can further exacerbate liver injury, increasing the risk of complications.

Baseline Assessment: HAA results provide information about the patient's hepatitis A status, aiding in risk assessment and management decisions.

Monitoring and Precautions: If the patient tests positive for hepatitis A, the nurse should initiate appropriate precautions to prevent transmission and closely monitor liver function during Fluoxetine therapy.